Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Barclays PLC Major Shareholding Notification 2021

Jul 8, 2021

5250_rns_2021-07-08_4a63b895-1827-40b1-a1f6-2cc072d2d3a4.html

Major Shareholding Notification

Open in viewer

Opens in your device viewer

National Storage Mechanism | Additional information

Form 8.3 - WILLIS TOWERS WATSON PLC

Ap19

FORM 8.3

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE

1. KEY INFORMATION

Name of person dealing (Note 1) Barclays PLC.
Company dealt in WILLIS TOWERS WATSON PLC
Class of relevant security to which the dealings being disclosed relate (Note 2) ORD
Date of dealing 7 JULY 2021

2. INTERESTS AND SHORT POSITIONS

(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)

Class of relevant security: ORD
Long Short
Number (%) Number (%)
(1) Relevant securities
1,870,958 1.45% 241,524 0.19%
(2) Derivatives (other than options):
72,359 0.06% 227,408 0.18%
(3) Options and agreements to
purchase/sell: 6,100 0.00% 6,100 0.00%
(4) TOTAL:
1,949,417 1.51% 475,032 0.37%

(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)

Class of relevant security: Long Short
Number (%) Number (%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total

Ap20

3. DEALINGS (Note 4)

(a) Purchases and sales

Purchase/sale Number of relevant securities Price per unit
Purchase 1 231.7300 USD
Purchase 1 230.4800 USD
Purchase 1 231.3300 USD
Purchase 2 229.9500 USD
Purchase 2 231.2550 USD
Purchase 2 230.5900 USD
Purchase 5 230.8780 USD
Purchase 6 231.1550 USD
Purchase 8 230.4687 USD
Purchase 30 231.4760 USD
Purchase 100 230.5200 USD
Purchase 100 231.1600 USD
Purchase 100 231.0600 USD
Purchase 100 230.8400 USD
Purchase 200 230.8250 USD
Purchase 368 230.9689 USD
Purchase 495 230.1279 USD
Purchase 812 230.0170 USD
Purchase 1,003 231.0008 USD
Purchase 1,127 231.0654 USD
Purchase 2,533 230.7638 USD
Purchase 4,574 230.6829 USD
Purchase 5,000 229.8125 USD
Purchase 14,590 230.9723 USD
Purchase 18,755 230.7700 USD
Sale 24 230.8800 USD
Sale 36 229.7800 USD
Sale 76 230.5000 USD
Sale 90 231.1222 USD
Sale 104 231.6305 USD
Sale 138 229.7500 USD
Sale 200 230.1300 USD
Sale 211 231.0358 USD
Sale 260 229.7576 USD
Sale 320 229.7639 USD
Sale 400 230.9500 USD
Sale 500 229.7864 USD
Sale 503 230.8635 USD
Sale 624 231.2281 USD
Sale 654 229.7607 USD
Sale 792 230.9915 USD
Sale 851 230.7700 USD
Sale 867 229.7632 USD
Sale 912 230.0722 USD
Sale 952 231.2935 USD
Sale 1,140 231.1509 USD
Sale 2,533 230.7638 USD
Sale 5,832 230.7699 USD
Sale 5,937 230.6762 USD
Sale 12,038 230.9309 USD
Sale 13,899 230.6367 USD

(b) Derivatives transactions (other than options transactions)

Product name,

e.g. CFD
Nature of transaction

(Note 6)
Number of relevant securities

(Note 7)
Price per unit

(Note 5)

(c) Options transactions in respect of existing relevant securities

(i) Writing, selling, purchasing or varying

Product name,

e.g. call option
Writing, selling, purchasing, varying etc. Number of securities to which the option relates (Note 7) Exercise price Type, e.g. American, European etc. Expiry date Option money paid/received per unit (Note 5)

(ii) Exercising

Product name,

e.g. call option
Number of securities Exercise price per unit (Note 5)

(d) Other dealings (including transactions in respect of new securities) (Note 4)

Nature of transaction

(Note 8)
Details Price per unit

(if applicable) (Note 5)

Ap21

2. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

None

Is a Supplemental Form 8 attached? (Note 9) YES

Date of disclosure 8 JULY 2021
Contact name Large Holdings Regulatory Operations
Telephone number 020 3134 7213
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection (Note 10)

Ap23

SUPPLEMENTAL FORM 8

IRISH TAKEOVER PANEL

DISCLOSURE UNDER RULE 8.1 AND RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2013

DETAILS OF OPEN POSITIONS

(This form should be attached to Form 8.1(a) & (b)(i), Form 8.1(b)(ii) or Form 8.3, as appropriate)

OPEN POSITIONS (Note 1)

Product name Written or Number of Exercise Type Expiry
purchased relevant securities price date
to which the option
or derivative
relates
Put Options Purchased -100 220.0000 American Jul 16, 2021
Call Options Purchased 100 240.0000 American Jul 16, 2021
Call Options Purchased 6,000 220.0000 American Jul 16, 2021
Put Options Purchased -6,000 200.0000 American Jul 16, 2021

Notes

1. Where there are open option positions or open derivative positions (except for CFDs), full details should be given. Full details of any existing agreements to purchase or to sell must also be given on this form.

2. For all prices and other monetary amounts, the currency must be stated.

For full details of disclosure requirements, see Rule 8 of the Rules. If in doubt, consult the Panel.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210708005482/en/

BARCLAYS PLC